Atlantic Lipid Lowering Treatment Optimization Program (ALLTOP): A Comprehensive Approach to the Treatment of Familial Hypercholesterolemia and Complex Dyslipidemias

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Hypercholesterolemia is recognized as the major driver for cardiovascular morbidity and mortality. To help address this in our community, Atlantic Medical Group (AMG) formed a lipid workgroup chaired by Robert D. Fishberg, MD, and Jeffrey N. Feldman, MD. The overarching goal of the lipid workgroup is to enhance the treatment of lipid disorders in those patients with abnormal lipid levels by improving access to resources at the primary care practice level and specialty level. We aim to develop a model for primary and secondary prevention that integrates guidelines for treatment at the practice level. Our primary objective is to identify high-risk patients by utilizing the electronic health record and partnering with patients' primary care providers to provide comprehensive medical management.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 120
Healthy Volunteers: f
View:

• LDL-C ≥160 mg/dL

• Untreated LDL-C ≥190 with family history of CAD

• Prior MI and currently without optimized lipid-lowering therapy

• Family history of CAD in first degree relative

• Personal history of CAD

• Untreated triglycerides \>500

• Elevated Lp(a) and/or high calcium scores

• Consenting individuals

Locations
United States
New Jersey
Atlantic Medical Group
NOT_YET_RECRUITING
Clark
Atlantic Medical Group
RECRUITING
Springfield
Contact Information
Primary
Robert D Fishberg, MD
robert.fishberg@atlantichealth.org
973-467-0005
Backup
Jeffrey N Feldman, MD
jeffrey.feldman@atlantichealth.org
908-686-9330
Time Frame
Start Date: 2024-07-01
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 250
Treatments
Other: LDL-C
Most recent LDL-C result
Sponsors
Collaborators: Regeneron Pharmaceuticals
Leads: Atlantic Health System

This content was sourced from clinicaltrials.gov